2012 Archive

Stay tuned with Golden Helix Foundation

Professor Maria Puiu from the University of Medicine and Pharmacy "Victor Babes", department of Medical Genetics in Timisoara has accepted the invitation to join the PGENI project on behalf of Romania.

Professor Rui Medeios from the Portuguese Institute of Oncology in Porto has agreed to represent Portugal as the coordinator of the PGENI project in his country.

Today, it has been announced that Italy will join the Pharmacogenomics for Every Nation Initiative. In particular, three institutes from different parts of the country, namely Cagliari (Prof. Maria del Zompo), Turin (Guiuseppe Saglio) and Rome (Prof. Giuseppe Novelli) will participate at this stage in the project with the prospect of including more institutes from Italy in the near future.

The 6th Golden Helix Pharmacogenomics Day was successfully organized in Belgrade, Serbia. The event was attended by 250 registered participants and co-organized with the Institute of Molecular Genetics and Genetic Engineering and the National Association for Enhancement and Development of Regenerative Medicine.

It has been announced today that the 2013 Golden Helix Symposium will be held in Dubai, United Arab Emirates, jointly with the 5th Pan-Arab Human Genetics Conference in spring 2013. The announcement was made jointly at the concluding remarks session of the 2012 Golden Helix Symposium in Turin, Italy by Professor Najib Al Khaja, Secretary General of Hamdan Medical Award (HMA) and President of Centre for Arab Genomic Studies (CAGS) and the members of the Golden Helix Institute Scientific Advisory Council Professors Fortina, Patrinos and Innocenti. The exact dates and scientific program will be announced soon.

Please click here to read the related press release.

The 2012 Golden Helix Symposium was held in Turin. The meeting was attended by over 270 registered participants from over 30 countries, e.g. Brazil, China, South Africa, United Arab Emirates, Russia, Singapore, and several European countries and supported by all major biotechnology companies, such as Agilent, Illumina, Roche Diagnostics, Life Technologies, etc. Please click here to access the scientific program of this meeting.

Page 2 of 4